Having elevated contents of GlcNAc-asparagine-containing peptides and the differential abundance of specific proteins detected in NGLY1-knockdown melanoma cells (Supplementary Figure S5; Supplementary Table S4), we examined proteomic changes in melanoma cells treated with our NGLY1 inhibitors. Here, NGLY1 is linked to melanoma.